Teladoc Health, Inc. (TDOC) financial statements (2021 and earlier)

Company profile

Business Address 2 MANHATTANVILLE ROAD
PURCHASE, NY 10577
State of Incorp. DE
Fiscal Year End December 31
SIC 8011 - Offices and Clinics of Doctors of Medicine (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments517491473434424473132
Cash and cash equivalents514475440434424458106
Short-term investments31632  1527
Receivables57545051444038
Other undisclosed current assets1413105665118
Total current assets:588558533541533523179
Noncurrent Assets
Operating lease, right-of-use asset262829 
Property, plant and equipment10101010101010
Intangible assets, net (including goodwill)9729669879739851,0011,010
Goodwill746738748734737744745
Intangible assets, net (excluding goodwill)225229239238247257265
Other noncurrent assets7661111
Other undisclosed noncurrent assets   27   
Total noncurrent assets:1,0151,0101,0331,0119961,0121,021
TOTAL ASSETS:1,6031,5681,5651,5521,5291,5351,200
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities50483338413937
Accounts payable9668856
Accrued liabilities6833267
Employee-related liabilities31251818282124
Taxes payable355533 
Interest and dividends payable1414141
Deferred revenue121412 
Debt555    
Restructuring reserve 000001
Estimated litigation liability1111111
Contract with customer, liability118  
Other liabilities8697344
Other undisclosed current liabilities1410101591514
Total current liabilities:90857072625857
Noncurrent Liabilities
Long-term debt and lease obligation465460454421415409403
Long-term debt, excluding current maturities440434427421415409403
Operating lease, liability252626 
Liabilities, other than long-term debt3330395666
Deferred income tax liabilities222332 
Other liabilities12775666
Total noncurrent liabilities:499489492426421414408
Total liabilities:589575563497483472465
Stockholders' equity
Stockholders' equity attributable to parent1,0149941,0031,0021,0131,028699
Common stock0000000
Additional paid in capital1,5391,5101,4831,4571,4351,4161,062
Accumulated other comprehensive loss(17)(28)(13)(17)(13)(4)(3)
Accumulated deficit(508)(488)(468)(439)(409)(384)(361)
Total stockholders' equity:1,0149941,0031,0021,0131,028699
Other undisclosed liabilities and equity   53323535
TOTAL LIABILITIES AND EQUITY:1,6031,5681,5651,5521,5291,5351,200

Income statement (P&L) ($ in millions)

12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
Revenues15613813012912311195
Cost of revenue(56)(44)(44)(45)(40)(34)(28)
Cost of goods and services sold(55)(43)(42)(45)   
Gross profit:101948784837767
Operating expenses(116)(113)(109)(106)(91)(82)(76)
Other undisclosed operating loss   (0)(10)(10)(9)
Operating loss:(16)(20)(22)(23)(18)(16)(18)
Loss from continuing operations before equity method investments, income taxes:(16)(20)(22)(23)(18)(16)(18)
Other undisclosed loss from continuing operations before income taxes(8)(8)(7)(7)(7)(8)(7)
Loss from continuing operations before income taxes:(23)(28)(29)(29)(25)(23)(25)
Income tax expense (benefit)47(0)(1)(0)0(0)
Net loss available to common stockholders, diluted:(19)(20)(29)(30)(25)(23)(25)

Comprehensive Income ($ in millions)

12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
Net loss:(19)(20)(29)(30)(25)(23)(25)
Other comprehensive income (loss) (16)4(4)   
Other undisclosed comprehensive loss(4)      
Comprehensive loss:(23)(36)(25)(34)(25)(23)(25)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent15   (9)(2)(6)
Comprehensive loss, net of tax, attributable to parent:(8)(36)(25)(34)(34)(25)(31)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: